Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Tourmaline Bio, Inc. (TRML) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Tourmaline Bio, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1827506.
Total stock buying since 2021: $13,741,049.
Total stock sales since 2021: $2,656,084.
Total stock option exercises since 2021: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 107,000 | $3,348,415 | 0 | $0 | 0 | $0 |
| 2023 | 49,150 | $643,256 | 510,054 | $1,186,084 | 0 | $0 |
| 2022 | 195,944 | $739,378 | 525,000 | $1,470,000 | 0 | $0 |
| 2021 | 530,000 | $9,010,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-08 | 7,000 | $98,415 | 0 | $0 | 0 | $0 |
| 2024-01 | 100,000 | $3,250,000 | 0 | $0 | 0 | $0 |
| 2023-11 | 5,000 | $85,270 | 0 | $0 | 0 | $0 |
| 2023-10 | 44,150 | $557,986 | 0 | $0 | 0 | $0 |
| 2023-06 | 0 | $0 | 250,003 | $618,975 | 0 | $0 |
| 2023-04 | 0 | $0 | 232,729 | $510,890 | 0 | $0 |
| 2023-03 | 0 | $0 | 17,271 | $35,591 | 0 | $0 |
| 2023-02 | 0 | $0 | 10,051 | $20,628 | 0 | $0 |
| 2022-08 | 0 | $0 | 525,000 | $1,470,000 | 0 | $0 |
| 2022-07 | 195,944 | $739,378 | 0 | $0 | 0 | $0 |
| 2021-05 | 530,000 | $9,010,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-08-21 | Kulkarni Sandeep Chidambar (CEO) | Buy | 1,779 | 14.85 | 26,418 |
| 2024-08-16 | Kulkarni Sandeep Chidambar (CEO) | Buy | 5,221 | 13.79 | 71,997 |
| 2024-01-29 | Mcdade Mark | Buy | 100,000 | 32.50 | 3,250,000 |
| 2023-11-17 | Thiara Parvinder (Director) | Buy | 1,000 | 17.31 | 17,310 |
| 2023-11-17 | Kulkarni Sandeep Chidambar (CEO) | Buy | 4,000 | 16.99 | 67,960 |
| 2023-10-27 | Castelein Caley (Director) | Buy | 15,800 | 14.55 | 229,890 |
| 2023-10-26 | Kulkarni Sandeep Chidambar (CEO) | Buy | 5,000 | 12.25 | 61,250 |
| 2023-10-25 | Thiara Parvinder (Director) | Buy | 2,000 | 12.12 | 24,240 |
| 2023-10-25 | Castelein Caley (Director) | Buy | 4,200 | 12.07 | 50,694 |
| 2023-10-24 | Thiara Parvinder (Director) | Buy | 5,000 | 10.66 | 53,300 |
| 2023-10-24 | Kulkarni Sandeep Chidambar (CEO) | Buy | 4,650 | 10.68 | 49,662 |
| 2023-10-24 | Kantoff Aaron (Director) | Buy | 7,500 | 11.86 | 88,950 |
| 2023-06-14 | Ildstad Suzanne (Director) | Sale | 12,942 | 2.49 | 32,238 |
| 2023-06-13 | Ildstad Suzanne (Director) | Sale | 14,208 | 2.56 | 36,344 |
| 2023-06-12 | Ildstad Suzanne (Director) | Sale | 16,870 | 2.59 | 43,727 |
| 2023-06-09 | Ildstad Suzanne (Director) | Sale | 25,419 | 2.46 | 62,632 |
| 2023-06-08 | Ildstad Suzanne (Director) | Sale | 40,642 | 2.48 | 100,792 |
| 2023-06-07 | Ildstad Suzanne (Director) | Sale | 75,001 | 2.39 | 179,102 |
| 2023-06-06 | Ildstad Suzanne (Director) | Sale | 25,549 | 2.53 | 64,587 |
| 2023-06-05 | Ildstad Suzanne (Director) | Sale | 7,841 | 2.52 | 19,751 |
| 2023-06-02 | Ildstad Suzanne (Director) | Sale | 15,818 | 2.50 | 39,624 |
| 2023-06-01 | Ildstad Suzanne (Director) | Sale | 15,713 | 2.56 | 40,178 |
| 2023-04-21 | Ildstad Suzanne (Director) | Sale | 15,004 | 2.35 | 35,229 |
| 2023-04-20 | Ildstad Suzanne (Director) | Sale | 46,990 | 2.33 | 109,298 |
| 2023-04-19 | Ildstad Suzanne (Director) | Sale | 21,753 | 2.16 | 47,051 |
| 2023-04-18 | Ildstad Suzanne (Director) | Sale | 49,211 | 2.15 | 105,803 |
| 2023-04-17 | Ildstad Suzanne (Director) | Sale | 99,771 | 2.14 | 213,509 |
| 2023-03-17 | Ildstad Suzanne (Director) | Sale | 10,436 | 2.06 | 21,539 |
| 2023-03-03 | Ildstad Suzanne (Director) | Sale | 6,806 | 2.06 | 13,993 |
| 2023-03-01 | Ildstad Suzanne (Director) | Sale | 29 | 2.05 | 59 |
| 2023-02-21 | Ildstad Suzanne (Director) | Sale | 3,500 | 2.05 | 7,185 |
| 2023-02-17 | Ildstad Suzanne (Director) | Sale | 3,612 | 2.05 | 7,404 |
| 2023-02-16 | Ildstad Suzanne (Director) | Sale | 2,939 | 2.06 | 6,039 |
| 2022-08-22 | Ildstad Suzanne (Chief Scientific Officer) | Sale | 525,000 | 2.80 | 1,470,000 |
| 2022-07-29 | Requadt Scott (Chief Executive Officer) | Buy | 39,382 | 4.25 | 167,373 |
| 2022-07-28 | Requadt Scott (Chief Executive Officer) | Buy | 3,090 | 4.25 | 13,132 |
| 2022-07-26 | Requadt Scott (Chief Executive Officer) | Buy | 5,528 | 4.24 | 23,438 |
| 2022-07-22 | Requadt Scott (Chief Executive Officer) | Buy | 9,444 | 3.75 | 35,415 |
| 2022-07-21 | Nader Francois (Director) | Buy | 36,500 | 3.72 | 135,780 |
| 2022-07-20 | Nader Francois (Director) | Buy | 52,000 | 3.62 | 188,240 |
| 2022-07-19 | Nader Francois (Director) | Buy | 50,000 | 3.52 | 176,000 |
| 2021-05-11 | Agarwala Sandip (Director) | Buy | 235,000 | 17.00 | 3,995,000 |
| 2021-05-11 | Blackstone Clarus Gp L.l.c. (10% Owner) | Buy | 30,000 | 17.00 | 510,000 |
| 2021-05-11 | Tammenoms Bakker Juliet (10% Owner) | Buy | 235,000 | 17.00 | 3,995,000 |
| 2021-05-11 | Schwarzman Stephen A (10% Owner) | Buy | 30,000 | 17.00 | 510,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of TRML listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Tourmaline Bio, Inc. (symbol TRML, CIK number 1827506) see the Securities and Exchange Commission (SEC) website.